Lisa M. Johansen

3.8k citations

23 papers · 2.8k indexed · 2 hit papers · h-index 19

Co-authors: Gene G. Olinger Joseph Lehár Margaret Lee Alexis A. Borisy William Avery Lisa E. Hensley Daniel G. Tenen Adrian Heilbut
Topics: Viral Infections and Outbreaks Research (6 papers)Acute Myeloid Leukemia Research (3 papers)Retinoids in leukemia and cellular processes (3 papers)
Cited by: Infectious Diseases Hematology Computational Theory and Mathematics
Journals: Blood Nature Biotechnology PLoS ONE
Partner nations: United States Japan Australia

In The Last Decade

Lisa M. Johansen

23 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synergistic drug combinations tend to improve therapeutically relevant selectivity

2009 742 citations Joseph Lehár, Andrew Krueger et al. Nature Biotechnology profile →
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

2014 475 citations Julie Dyall, Christopher M. Coleman et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by Lisa M. Johansen

Since Specialization

Citations

This map shows the geographic impact of Lisa M. Johansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Johansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Johansen more than expected).

Fields of papers citing papers by Lisa M. Johansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Johansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Johansen. The network helps show where Lisa M. Johansen may publish in the future.

Co-authorship network of co-authors of Lisa M. Johansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Johansen. A scholar is included among the top collaborators of Lisa M. Johansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Johansen. Lisa M. Johansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs 2021 ·Antimicrobial Agents and Chemotherapy ·(unknown),(unknown),Jessica Wagoner,(unknown),(unknown),Elizabeth A. Nelson,Qinfeng Huang,Yuying Liang,Lisa Evans DeWald,Lisa M. Johansen,Pamela J. Glass,Gene G. Olinger,Aleksandr Ianevski,Tero Aittokallio,Mary F. Paine,Susan L. Fink,Judith M. White,Stephen J. Polyak	30
2	Abstract CT032: A phase 1/2, open-label, multicenter, dose escalation and efficacy study of mRNA-2416, a lipid nanoparticle encapsulated mRNA encoding human OX40L, for intratumoral injection alone or in combination with durvalumab for patients with advanced malignancies 2020 ·Cancer Research ·Antonio Jimeno,Shilpa Gupta,Ryan J. Sullivan,T. Khanh,Wallace Akerley,Ding Wang,Deanna Teoh,Kurt A. Schalper,Sima J. Zacharek,Jing Sun,Andressa S. Laino,Joshua P. Frederick,Honghong Zhou,(unknown),Stéphanie Pascarella,Lisa M. Johansen,Pamela Cohen,Robert Meehan,Todd M. Bauer	36
3	Abstract CT210: A Phase I, open-label, multicenter, dose escalation study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral injection alone and in combination with immune checkpoint blockade 2019 ·Cancer Research ·Todd M. Bauer,Manish R. Patel,Antonio Jimeno,Ding Wang,Jessica D. McDermott,Sima J. Zacharek,(unknown),Lisa M. Johansen,Kristen Hopson,Joshua P. Frederick,Tal Zaks,Robert Meehan	12
4	Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication 2016 ·Scientific Reports ·Benjamin Bailly,Charles-Adrien Richard,Gajanand Sharma,(unknown),Lisa M. Johansen,(unknown),Vishal Pendharkar,(unknown),Marie Galloux,(unknown),Rui Cui,Gang Zou,Patrice Guillon,Mark von Itzstein,Jean‐François Eléouët,Ralf Altmeyer	35
5	Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists 2015 ·Journal of Virology ·Han Cheng,Calli M. Lear-Rooney,Lisa M. Johansen,(unknown),Zheng W. Chen,Gene G. Olinger,Lijun Rong	87
6	Supplementary Materials for A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity 2015 ·Lisa M. Johansen,Lisa Evans DeWald,Charles J. Shoemaker,Benjamin G. Hoffstrom,Calli M. Lear-Rooney,Andrea Stossel,Elizabeth A. Nelson,Sue E. Delos,James A. Simmons,Jill M. Grenier,Laura Pierce,Hassan Pajouhesh,Joseph Lehár,Lisa E. Hensley,Pamela J. Glass,Judith M. White,Gene G. Olinger	8
7	Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infectionbreakdown → 2014 ·Antimicrobial Agents and Chemotherapy ·Julie Dyall,Christopher M. Coleman,Brit J. Hart,Thiagarajan Venkataraman,Michael R. Holbrook,Jason Kindrachuk,Reed F. Johnson,Gene G. Olinger,Peter B. Jahrling,(unknown),Lisa M. Johansen,Calli M. Lear-Rooney,Pamela J. Glass,Lisa E. Hensley,Matthew B. Frieman	475
8	Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection 2013 ·PLoS ONE ·Charles J. Shoemaker,Kathryn L. Schornberg,Sue E. Delos,Corinne Scully,Hassan Pajouhesh,Gene G. Olinger,Lisa M. Johansen,Judith M. White	114
9	Correction: Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection 2013 ·PLoS ONE ·Charles J. Shoemaker,Kathryn L. Schornberg,Sue E. Delos,Corinne Scully,Hassan Pajouhesh,Gene G. Olinger,Lisa M. Johansen,Judith M. White	20
10	FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection 2013 ·Science Translational Medicine ·Lisa M. Johansen,Jennifer M. Brannan,Sue E. Delos,Charles J. Shoemaker,Andrea Stossel,Calli Lear,Benjamin G. Hoffstrom,Lisa Evans DeWald,Kathryn L. Schornberg,Corinne Scully,Joseph Lehár,Lisa E. Hensley,Judith M. White,Gene G. Olinger	249
11	Auranofin Protects against Anthrax Lethal Toxin-Induced Activation of the Nlrp1b Inflammasome 2010 ·Antimicrobial Agents and Chemotherapy ·Zachary L. Newman,(unknown),(unknown),Margaret Lee,Stephen H. Leppla,Mahtab Moayeri,Lisa M. Johansen	24
12	Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication 2010 ·Molecular Systems Biology ·Christopher M. Owens,(unknown),Jill M. Grenier,Ralf Altmeyer,Margaret Lee,Alexis A. Borisy,Joseph Lehár,Lisa M. Johansen	30
13	Synergistic drug combinations tend to improve therapeutically relevant selectivitybreakdown → 2009 ·Nature Biotechnology ·Joseph Lehár,Andrew Krueger,William Avery,Adrian Heilbut,Lisa M. Johansen,Edward Price,Richard J. Rickles,Glenn F. Short,Jane Staunton,Xiaowei Jin,Margaret Lee,Grant R. Zimmermann,Alexis A. Borisy	742
14	The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action 2007 ·Cancer Research ·Margaret Lee,Lisa M. Johansen,Yanzhen Zhang,Amy L. Wilson,Mitchell Keegan,William Avery,Peter J. Elliott,Alexis A. Borisy,Curtis T. Keith	90
15	The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cells 2003 ·Blood ·Francesco D’Alò,Lisa M. Johansen,Erik A. Nelson,Hanna S. Radomska,Erica N Evans,Pu Zhang,Claus Nerlov,Daniel G. Tenen	81
16	Heterozygous PU.1 mutations are associated with acute myeloid leukemia 2002 ·Blood ·Beatrice U. Mueller,Thomas Pabst,Motomi Osato,Norio Asou,Lisa M. Johansen,Mark D. Minden,Gerhard Behre,Wolfgang Hiddemann,Yoshiaki Ito,Daniel G. Tenen	185
17	c-Myc Is a Critical Target for C/EBPα in Granulopoiesis 2001 ·Molecular and Cellular Biology ·Lisa M. Johansen,Atsushi Iwama,Tracey Lodie,Koichi Sasaki,Dean W. Felsher,Todd R. Golub,Daniel G. Tenen	219
18	Genomic organization of human B-ATF, a target for regulation by EBV and HTLV-1 1998 ·Mammalian Genome ·Néva P. Meyer,Lisa M. Johansen,(unknown),(unknown),Kristi L. Williams,Elizabeth J. Taparowsky	12
19	IFP 35 Forms Complexes with B-ATF, a Member of the AP1 Family of Transcription Factors 1996 ·Biochemical and Biophysical Research Communications ·Xueyan Wang,Lisa M. Johansen,(unknown),Elizabeth J. Taparowsky	26
20	B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. 1995 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Lisa M. Johansen,Elizabeth J. Taparowsky	98

About Lisa M. Johansen

Lisa M. Johansen is a scholar working on Infectious Diseases, Emergency Medical Services and Hematology, having authored 23 papers that have together received 2.8k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (6 papers), Acute Myeloid Leukemia Research (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Infectious Diseases (941 citations), Hematology (313 citations) and Computational Theory and Mathematics (309 citations). Lisa M. Johansen has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Gene G. Olinger, Joseph Lehár, Margaret Lee, Alexis A. Borisy, William Avery, Lisa E. Hensley, Daniel G. Tenen, Adrian Heilbut, Richard J. Rickles and Glenn F. Short. Their work appears in journals such as Blood, Nature Biotechnology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact